Applicant profile
LeMaitre Vascular, Inc.
Lemaitre Vascular, Inc.
Hong Kong MDACS·United States·12 registered devices·Dec 23, 2021 – Sep 11, 2024
12
Total devices
2
Risk classes
2021
First registration
2024
Most recent
Applicant overview
Bilingual manufacturer details sourced from Hong Kong MDACS
- Applicant (EN)
- LeMaitre Vascular, Inc.
- Applicant (ZH)
- Lemaitre Vascular, Inc.
- Country
- United States美国
- Address
- 63 Second Avenue, Burlington, MA, 01803, United States63 Second Avenue, 伯灵顿, MA, 01803, 美
Timeline
- First registration
- Dec 23, 2021
- Most recent
- Sep 11, 2024
Risk class breakdown
II
6
IV
6
Recent MDACS registrations
Latest 15 devices linked to this applicant
| Device | Risk class | Authorised rep | Registered |
|---|---|---|---|
| Cardiovascular Patch Implants 心血管贴片植入物 | IV | Asia Actual Limited | Sep 11, 2024 |
| Clips, Implantable, Vascular, Intracranial 夹子, 植入式, 血管, 颅内 | IV | Asia Actual Limited | Mar 02, 2023 |
| Catheters, Vascular, Occlusion, Temporary 导管,血管,闭塞,临时 | II | Asia Actual Limited | Oct 18, 2022 |
| Catheters, Vascular, Occlusion, Temporary 导管,血管,闭塞,临时 | IV | Asia Actual Limited | Oct 18, 2022 |
| Catheters, Vascular, Occlusion, Temporary 导管,血管,闭塞,临时 | II | Asia Actual Limited | Oct 18, 2022 |
| Catheters, Vascular, Occlusion, Temporary 导管,血管,闭塞,临时 | IV | Asia Actual Limited | Oct 18, 2022 |
| Cardiovascular Patch Implants 心血管贴片植入物 | IV | Asia Actual Limited | Sep 20, 2022 |
| Catheters, Vascular, Embolectomy/Thrombectomy 导管、血管、栓塞切除术/血栓切除术 | II | Asia Actual Limited | Apr 29, 2022 |
| Shunts, Carotid Artery 分流器,颈动脉 | IV | Asia Actual Limited | Apr 29, 2022 |
| Catheters, Vascular, Embolectomy/Thrombectomy 导管、血管、栓塞切除术/血栓切除术 | II | Asia Actual Limited | Apr 29, 2022 |
| Catheters, Vascular, Perfusion 导管、血管、灌注 | II | Asia Actual Limited | Apr 20, 2022 |
| Valvulotomes 瓣膜组 | II | Asia Actual Limited | Dec 23, 2021 |
About this profile
LeMaitre Vascular, Inc. is associated with 12 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.